Results 161 to 170 of about 22,616 (177)
Some of the next articles are maybe not open access.
Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma
Annals of Oncology, 2002Alfred Penfornis, C Gicquel, E Baudin
exaly
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2017
Adrenocortical carcinoma is a rare entity. However, it is the most common type of cancerous adrenal gland tumor with poor prognosis. Approximately 4 to 12 per 1 million people develop this type of tumor, which begins in the adrenal cortex. Adrenocortical carcinoma can occur at any age. Women tend to be diagnosed slightly more often than men.
openaire +1 more source
Adrenocortical carcinoma is a rare entity. However, it is the most common type of cancerous adrenal gland tumor with poor prognosis. Approximately 4 to 12 per 1 million people develop this type of tumor, which begins in the adrenal cortex. Adrenocortical carcinoma can occur at any age. Women tend to be diagnosed slightly more often than men.
openaire +1 more source
Prognostic Parameters of Metastatic Adrenocortical Carcinoma
Journal of Clinical Endocrinology and Metabolism, 2007Eric Baudin +2 more
exaly
Oral cavity and oropharyngeal squamous cell carcinoma—an update
Ca-A Cancer Journal for Clinicians, 2015Angela C Chi, Terry A Day
exaly
Surgical Management of Adrenocortical Carcinoma
Endocrinology and Metabolism Clinics of North America, 2015William B Inabnet
exaly
Adrenocortical carcinoma: Past, present, and future
Journal of Surgical Oncology, 2012Murray Brennan
exaly